The current meta-analysis combined preclinical and clinical studies and verified that soybean could protect the liver in NAFLD by regulating lipid metabolism and oxidative stress factors <i>via</i> the Akt/AMPK/PPARα signaling pathway. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.